Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Copenhagen University Hospital at Herlev
ClinicalTrials.gov Identifier:
NCT00718055
First received: October 4, 2006
Last updated: February 9, 2009
Last verified: February 2009
  Purpose

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan


Condition Phase
Neoplasm Metastasis
Liver
Colorectal Neoplasms
Magnetic Resonance Imaging
Contrast Media
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: MR Skanning Med Leverspecifikt Oralt Kontraststof Sammenlignet Med CT Skanning Hos Colorectalcancer Patienter Med Levermetastaser

Resource links provided by NLM:


Further study details as provided by Copenhagen University Hospital at Herlev:

Estimated Enrollment: 50
Study Start Date: November 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

consekutive group of liver metastatic patients

Criteria

Inclusion Criteria:

  • biopsy proved liver metastasis

Exclusion Criteria:

  • pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00718055

Locations
Denmark
Copenhagen Uni. Hospital at Herlev dept. of Radiology
Herlev, Denmark, 2730
Sponsors and Collaborators
Copenhagen University Hospital at Herlev
Investigators
Principal Investigator: Vibeke Løgager, M.D. Copenhagen University Hospital at Herlev
  More Information

No publications provided

Responsible Party: Vibeke Løgager, Herlev Hospital
ClinicalTrials.gov Identifier: NCT00718055     History of Changes
Other Study ID Numbers: KA-20060096
Study First Received: October 4, 2006
Last Updated: February 9, 2009
Health Authority: Denmark: Danish Medicines Agency

Keywords provided by Copenhagen University Hospital at Herlev:
MRI
liverspecific
contrast
colorectal
metastases

Additional relevant MeSH terms:
Neoplasms
Neoplasm Metastasis
Colorectal Neoplasms
Neoplastic Processes
Pathologic Processes
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on October 16, 2014